DeutschNewstral
Article
bizjournals.com on 2020-06-19 19:38
Baltimore biotech developing diabetes treatments raises $20.5M
Related news
- Baltimore biotech firm raising $111.5 millionbizjournals.com
- Former Sucampo CEO lands at Baltimore biotechbizjournals.com
- St. Louis biotech startup relocates to Baltimorebizjournals.com
Apple has a secret team developing diabetes treatmentsNew York Post- Baltimore biotech WindMIL Therapeutics raises $32.5 millionbizjournals.com
Union Collective in Baltimore rapidly developingthedailyrecord.com- Baltimore biotech targeting rare diseases raises $4 millionbizjournals.com
- Baltimore biotech raises $1.6M to put toward wound healing solutionbizjournals.com
- Baltimore biotech Delfi Diagnostics raises $100 million funding roundbizjournals.com
- Baltimore biotech firm launches kit for rapid DNA extractionthedailyrecord.com
Biotech company to manufacture Ebola treatment in Baltimorewkrg.com- California public company Pacific Biosciences acquires Baltimore biotechbizjournals.com
- Baltimore biotech bringing new cancer diagnosis test to marketbizjournals.com
- Opko Health acquires biotech developing novel cancer treatments for $300 millionbizjournals.com
Port Covington: Developing a Futuristic Vision of Baltimoreafro.com- Baltimore vaccine firm is developing a Zika vaccinebizjournals.com
- Baltimore firm developing blindness-fighting therapies raises $35Mbizjournals.com
- PGDx becomes latest Baltimore biotech to raise mega-deal, with $103M Series Cbizjournals.com
- Baltimore biotech raises $4M to fuel trials for Covid vaccine, rare disease drugbizjournals.com
- St. Louis biotech KaloCyte joins UM BioPark, consolidates team in Baltimorebizjournals.com